Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.
Journal of Immunology Research|October 8, 2020
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal AdenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignanciesRoman K Thomas, Martin L Sos, Thomas Zander, et al.
Plos One|August 29, 2019
The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomyChristoph Baltin, Florian Kron, Alexander Urbanski, et al.
Plos One|December 31, 2014
Age-related loss of lumbar spinal lordosis and mobility--a study of 323 asymptomatic volunteersMarcel Dreischarf, Laia Albiol, Antonius Rohlmann, et al.
Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.
Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.
Annals of Surgical Oncology|April 11, 2022
Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal CancerWolfgang Schroeder, Markus P H Ghadimi, Hans Schloesser, et al.
Translational Oncology|October 15, 2018
Genomic Characterization of TP53-Wild-Type Esophageal CarcinomaAlexander Quaas, Carina Heydt, Florian Gebauer, et al.
Molecules (Basel, Switzerland)|September 2, 2020
Influence of the Molecular Weight and the Presence of Calcium Ions on the Molecular Interaction of Hyaluronan and DPPCThomas Zander, Vasil M Garamus, Andra Dédinaité, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.
Journal of Immunology Research|October 8, 2020
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal AdenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignanciesRoman K Thomas, Martin L Sos, Thomas Zander, et al.
Plos One|August 29, 2019
The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomyChristoph Baltin, Florian Kron, Alexander Urbanski, et al.
Plos One|December 31, 2014
Age-related loss of lumbar spinal lordosis and mobility--a study of 323 asymptomatic volunteersMarcel Dreischarf, Laia Albiol, Antonius Rohlmann, et al.
Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.
Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.
Annals of Surgical Oncology|April 11, 2022
Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal CancerWolfgang Schroeder, Markus P H Ghadimi, Hans Schloesser, et al.
Translational Oncology|October 15, 2018
Genomic Characterization of TP53-Wild-Type Esophageal CarcinomaAlexander Quaas, Carina Heydt, Florian Gebauer, et al.
Molecules (Basel, Switzerland)|September 2, 2020
Influence of the Molecular Weight and the Presence of Calcium Ions on the Molecular Interaction of Hyaluronan and DPPCThomas Zander, Vasil M Garamus, Andra Dédinaité, et al.
Pageof 21